Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/57751Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cabrera-Serrano A.J. | - |
| dc.contributor.author | Sanchez-Maldonado J.M. | - |
| dc.contributor.author | Clavero E. | - |
| dc.contributor.author | MacAuda A. | - |
| dc.contributor.author | Horst R.T. | - |
| dc.contributor.author | Jurczyszyn A. | - |
| dc.contributor.author | Clay-Gilmour A. | - |
| dc.contributor.author | Stein A. | - |
| dc.contributor.author | Hildebrandt M.A.T. | - |
| dc.contributor.author | Weinhold N. | - |
| dc.contributor.author | Buda G. | - |
| dc.contributor.author | Garcia-Sanz R. | - |
| dc.contributor.author | Tomczak W. | - |
| dc.contributor.author | Vogel U. | - |
| dc.contributor.author | Jerez A. | - |
| dc.contributor.author | Zawirska D. | - |
| dc.contributor.author | Watek M. | - |
| dc.contributor.author | Hofmann J.N. | - |
| dc.contributor.author | Landi S. | - |
| dc.contributor.author | Spinelli J.J. | - |
| dc.contributor.author | Butrym A. | - |
| dc.contributor.author | Martinez-Lopez J. | - |
| dc.contributor.author | Galimberti S. | - |
| dc.contributor.author | Sarasquete M.E. | - |
| dc.contributor.author | Subocz E. | - |
| dc.contributor.author | Iskierka-Jazdzewska E. | - |
| dc.contributor.author | Giles G.G. | - |
| dc.contributor.author | Rybicka-Ramos M. | - |
| dc.contributor.author | Kruszewski M. | - |
| dc.contributor.author | Abildgaard N. | - |
| dc.contributor.author | Kadar K. | - |
| dc.contributor.author | Razny M. | - |
| dc.contributor.author | Cozen W. | - |
| dc.contributor.author | Bhatti P. | - |
| dc.contributor.author | Dudzinski M. | - |
| dc.contributor.author | Druzd-Sitek A. | - |
| dc.contributor.author | Li Y. | - |
| dc.contributor.author | Norman A.D. | - |
| dc.contributor.author | Zaucha J.M. | - |
| dc.contributor.author | Vieira Reis R.M. | - |
| dc.contributor.author | Markiewicz M. | - |
| dc.contributor.author | Campa D. | - |
| dc.contributor.author | Dumontet C. | - |
| dc.contributor.author | Vangsted A.J. | - |
| dc.contributor.author | Brown E.E. | - |
| dc.contributor.author | Vachon C.M. | - |
| dc.contributor.author | Netea M.G. | - |
| dc.contributor.author | Canzian F. | - |
| dc.contributor.author | Forsti A. | - |
| dc.contributor.author | Sainz J. | - |
| dc.date.accessioned | 2026-04-14T23:21:56Z | - |
| dc.date.available | 2026-04-14T23:21:56Z | - |
| dc.date.copyright | 2023 | - |
| dc.date.issued | 2026-03-31 | en |
| dc.identifier.citation | Bone Marrow Transplantation. Conference: 49th Annual Meeting of the EBMT. Paris France. 58(Supplement 1) (pp 480-481), 2023. Date of Publication: 01 Nov 2023. | - |
| dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/57751 | - |
| dc.description.abstract | Background: Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. Method(s): We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1x10-9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs) and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). Result(s): After meta-analysis of genetic data from three independent cohorts of European ancestry including 13387 subjects (6863 MM patients and 6524 controls), we identified six loci, ULK4, IKBKE, ATG5, CD46, CDKN2A, and PARK2, associated with MM risk (p=4.79x10-4~ 5.82x10-14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating levels of vitamin D3 (p=4.0x10-4), whereas the IKBKErs17433804 SNP correlated with levels of transitional CD24+CD38+ B cells (p=4.8x10-4) and circulating serum levels of MCP-2 (p=3.6*10-4). We also found that the CD46rs1142469 SNP correlated with numbers of CD19+ B cells, CD19+CD3-B cells, CD5+IgD-cells, IgM-cells, IgD-IgM-cells, and CD4-CD8-PBMCs (p=4.9x10-4-8.6x10-4) and circulating levels of IL20 (p=0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27-cells (p=9.3x10-4). Conclusion(s): This study reports the consistent association of genetic polymorphisms within the ULK4, ATG5, CDKN2A, IKBKE, CD46 and PARK2 loci in modulating MM risk and provides new insights into the functional role of ULK4, IKBKE, CD46, and CDKN2A polymorphisms in disease pathogenesis. Additional studies are still necessary to confirm the functional impact of these SNPs on the risk of developing MM and to identify the biological mechanisms behind the ATG5 association. | - |
| dc.publisher | Springer Nature | - |
| dc.subject.mesh | aged | - |
| dc.subject.mesh | autophagy (cellular) | - |
| dc.subject.mesh | B lymphocyte | - |
| dc.subject.mesh | bone marrow | - |
| dc.subject.mesh | carcinogenesis | - |
| dc.subject.mesh | cell survival | - |
| dc.subject.mesh | etiology | - |
| dc.subject.mesh | gene | - |
| dc.subject.mesh | genetic polymorphism | - |
| dc.subject.mesh | genetic variation | - |
| dc.subject.mesh | immune response | - |
| dc.subject.mesh | macrophage | - |
| dc.subject.mesh | monocyte | - |
| dc.subject.mesh | multiple myeloma | - |
| dc.subject.mesh | neoplastic cell transformation | - |
| dc.subject.mesh | pathogenesis | - |
| dc.subject.mesh | peripheral blood mononuclear cell | - |
| dc.subject.mesh | plasma cell | - |
| dc.subject.mesh | protein defect | - |
| dc.subject.mesh | single nucleotide polymorphism | - |
| dc.subject.mesh | biological marker | - |
| dc.subject.mesh | CD3 antigen | - |
| dc.subject.mesh | CD4 antigen | - |
| dc.subject.mesh | CD5 antigen | - |
| dc.subject.mesh | colecalciferol | - |
| dc.subject.mesh | immunoglobulin D | - |
| dc.subject.mesh | immunoglobulin M | - |
| dc.subject.mesh | membrane cofactor protein | - |
| dc.subject.mesh | monocyte chemotactic protein 2 | - |
| dc.subject.mesh | paraprotein | - |
| dc.title | POLYMORPHISMS WITHIN AUTOPHAGY-RELATED GENES AS SUSCEPTIBILITY BIOMARKERS for MULTIPLE MYELOMA: A META-ANALYSIS of THREE LARGE COHORTS. | - |
| dc.type | Conference Abstract | - |
| dc.identifier.affiliation | Monash University - School of Clinical Sciences at Monash Health | - |
| dc.description.conferencename | 49th Annual Meeting of the EBMT | - |
| dc.description.conferencelocation | Paris, France | - |
| dc.identifier.doi | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1038/s41409-023-02056-7 | - |
| local.date.conferencestart | 2023-04-23 | - |
| dc.identifier.institution | (Cabrera-Serrano, Sanchez-Maldonado, Sainz) Genomic Oncology Area, Genyo, Centre for Genomics and Oncological Research, Pfizer, University of Granada / Andalusian Regional Government, Pts, Granada, Spain | - |
| dc.identifier.institution | (Cabrera-Serrano, Sanchez-Maldonado, Sainz) Instituto de Investigacion Biosanataria IBs., Granada, Spain | - |
| dc.identifier.institution | (Cabrera-Serrano, Sanchez-Maldonado, Clavero, Sainz) Virgen de Las Nieves University Hospital, Granada, Spain | - |
| dc.identifier.institution | (MacAuda, Stein) Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany | - |
| dc.identifier.institution | (Horst, Li) Radboud University, Medical Center, Nijmegen, Netherlands | - |
| dc.identifier.institution | (Horst) CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria | - |
| dc.identifier.institution | (Jurczyszyn) Jagiellonian University Medical College, Krakow, Poland | - |
| dc.identifier.institution | (Clay-Gilmour) Arnold School of Public Health, University of South Carolina, Greenville, United States | - |
| dc.identifier.institution | (Clay-Gilmour, Norman) Division of Epidemiology, Mayo Clinic, Rochester, United States | - |
| dc.identifier.institution | (Hildebrandt) The University of Texas, Md Anderson Cancer Center, Houston, United States | - |
| dc.identifier.institution | (Weinhold) Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States | - |
| dc.identifier.institution | (Weinhold) University of Heidelberg, Heidelberg, Germany | - |
| dc.identifier.institution | (Buda, Galimberti) University of Pisa/AOUP, Pisa, Italy | - |
| dc.identifier.institution | (Garcia-Sanz, Sarasquete) Diagnostic Laboratory Unit in Hematology, University Hospital of Salamanca, Ibsal, Ciberonc, Centro de Investigacion Del Cancer-IBMCC (USAL-CSIC), Salamanca, Spain | - |
| dc.identifier.institution | (Tomczak) Medical University of Lublin, Lublin, Poland | - |
| dc.identifier.institution | (Vogel) National Research Centre for the Working Environment, Copenhagen, Denmark | - |
| dc.identifier.institution | (Jerez) University Hospital Morales Meseguer, Imib, Murcia, Spain | - |
| dc.identifier.institution | (Zawirska) University Hospital, Krakow, Poland | - |
| dc.identifier.institution | (Watek) Holycross Medical Oncology Center, Kielce, Poland | - |
| dc.identifier.institution | (Watek) Institute of Hematology and Transfusion Medicine, Warsaw, Poland | - |
| dc.identifier.institution | (Hofmann) Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, United States | - |
| dc.identifier.institution | (Landi) Italy | - |
| dc.identifier.institution | (Spinelli) Division of Population Oncology, Bc Cancer, British Columbia, Canada | - |
| dc.identifier.institution | (Spinelli) School Od Population and Public Health, University of British Columbia, British Columbia, Canada | - |
| dc.identifier.institution | (Butrym) Wroclaw Medical Universtiy, Wroclaw, Poland | - |
| dc.identifier.institution | (Butrym) Alfred Sokolowski Specialist Hospital in Walbrzych Oncology Support Centre for Clinical Trials, Walbrzych, Poland | - |
| dc.identifier.institution | (Martinez-Lopez) Hospital 12 de Octubre, Compluntense University, Cnio, Ciberonc, Madrid, Spain | - |
| dc.identifier.institution | (Subocz) Military Institute of Medicine, Warsaw, Poland | - |
| dc.identifier.institution | (Iskierka-Jazdzewska) Medical University of Lodz, Lodz, Poland | - |
| dc.identifier.institution | (Giles) Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia | - |
| dc.identifier.institution | (Giles) Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia | - |
| dc.identifier.institution | (Giles) Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia | - |
| dc.identifier.institution | (Rybicka-Ramos) Specialist Hospital No.1 in Bytom, Academy of Silesia, Katowice, Poland | - |
| dc.identifier.institution | (Kruszewski) University Hospital No. 2, Bydgoszcz, Poland | - |
| dc.identifier.institution | (Abildgaard) Odense University Hospital, Odense, Denmark | - |
| dc.identifier.institution | (Kadar) St Johns Hospital, Budapest, Hungary | - |
| dc.identifier.institution | (Razny) Rydygier Hospital, Cracow, Poland | - |
| dc.identifier.institution | (Cozen, Markiewicz) Silesian Medical University, Katowice, Poland | - |
| dc.identifier.institution | (Bhatti) Cancer Control Research, Bc Cancer, Vancouver, Canada | - |
| dc.identifier.institution | (Bhatti) Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States | - |
| dc.identifier.institution | (Dudzinski) Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland | - |
| dc.identifier.institution | (Druzd-Sitek) Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland | - |
| dc.identifier.institution | (Li) Centre for Individualised Infection Medicine (CiiM) & Twincore, Jt. Ventures between the Helmholtz-Ctr. for Infect. Res. (HZI) and the Hannover Medical School (MHH), Hannover, Germany | - |
| dc.identifier.institution | (Norman) Genetic Epidemiology and Risk Assessment Program, Mayo Clinic Comprehensive Cancer Center, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, United States | - |
| dc.identifier.institution | (Zaucha) Medical University of Gdansk, Gdansk, Poland | - |
| dc.identifier.institution | (Vieira Reis) Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal | - |
| dc.identifier.institution | (Vieira Reis) Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil | - |
| dc.identifier.institution | (Campa) University of Pisa, Heidelberg, Germany | - |
| dc.identifier.institution | (Dumontet) Cancer Research Center of Lyon, Hospices Civils de Lyon, Lyon, France | - |
| dc.identifier.institution | (Vangsted) Rigshospitalet, Copenhagen University, Copenhagen, Denmark | - |
| dc.identifier.institution | (Brown) The University of Alabama at Birmingham, Birmingham, United States | - |
| dc.identifier.institution | (Vachon) Mayo Clinic, Rochester, United States | - |
| dc.identifier.institution | (Netea) Radboud University, Medical Center, Radboud, Netherlands | - |
| dc.identifier.institution | (Canzian, Forsti) German Cancer Research Center, Heidelberg, Germany | - |
| dc.identifier.institution | (Sainz) University of Granada (UGR), Granada, Spain | - |
| local.date.conferenceend | 2023-04-26 | - |
| dc.identifier.affiliationmh | (Giles) Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| item.openairetype | Conference Abstract | - |
| item.cerifentitytype | Publications | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| Appears in Collections: | Conference Abstracts | |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
